2015
DOI: 10.1016/j.humimm.2015.09.003
|View full text |Cite
|
Sign up to set email alerts
|

HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
49
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(50 citation statements)
references
References 52 publications
1
49
0
Order By: Relevance
“…Interestingly, we found that NKG2C surface expression was significantly lower on NK cells stimulated with the anti-NKG2C Ab relative to those stimulated with the anti-NK-G2A/C Ab ( Figure 1A). This effect may be due to downmodulation or internalization of NKG2C, a phenomenon that has been previously described upon NK cell stimulation with HLA-E:G peptide complexes (15,44). For direct measurement of proliferation, we labeled NK cells with CellTrace dye prior to culturing and repeated these culture experiments.…”
Section: Resultsmentioning
confidence: 98%
“…Interestingly, we found that NKG2C surface expression was significantly lower on NK cells stimulated with the anti-NKG2C Ab relative to those stimulated with the anti-NK-G2A/C Ab ( Figure 1A). This effect may be due to downmodulation or internalization of NKG2C, a phenomenon that has been previously described upon NK cell stimulation with HLA-E:G peptide complexes (15,44). For direct measurement of proliferation, we labeled NK cells with CellTrace dye prior to culturing and repeated these culture experiments.…”
Section: Resultsmentioning
confidence: 98%
“…We know that the interaction KIR-HLA has two sides of KIR and HLA. For example overexpression of HLA-E on surface of colorectal cancer cells can result in inhibition of NKs [53] and such patients have better survival from the disease [54]; of course the receptor of HLA-E is CD94/NKG2a [55], [56]. KIR2DL1 and 2DS1 interact with HLA-C2, and KIR2DL2, 2DL3 and 2DS2 interact with HLA-C1 [57]; so every mathematical predict do not occur.…”
Section: Resultsmentioning
confidence: 99%
“…Subtle differences in HLA‐E bound peptides can lead to NK cell activation, thus, it is conceivable that HCMV peptides are recognized by NKG2C via HLA‐E presentation, thereby promoting preferential expansion of NKG2C + cells . Certain HCMV derived peptides loaded on HLA‐E do promote degranulation of NK cells bearing NKG2C, in the absence of its inhibitory counterpart NKG2A, consistent with the predominant phenotype of functionally mature NKG2C + CD57 + NK cells [, ]. The cytokine environment and possibly the HLA‐E/NKG2C stimulatory axis may be subdued in our in vitro system compared to others.…”
Section: Resultsmentioning
confidence: 99%